 |
        |
Syntinate |
Technology| Resorbable |
Syntinate products are resorbable via diffusion into surrounding body fluids and normal phagocytosis. |
| Tunable Solubility |
Water insoluble components may be incorporated into the Syntinate Technology, allowing tunability of resorption and/or water resistance. |
| Anhydrous |
A unique characteristic of the Syntinate system is that water is not necessary for most formulations. Without the presence of water, shelf life stability of a wide variety of products may be maintained for extended periods of time. |
| Non-Toxic and Broadly Biocompatible |
Syntinate components are selected from materials that have established safety profiles and whose use in common medical implants is known. |
| Radiation Sterilizable |
Most Syntinate compositions can be radiation-sterilized. Additives, depending on their nature, either may be combined with the Syntinate carrier and terminally sterilized in a commercial package, or may be pre-sterilized and then aseptically combined with an appropriate, radiation-sterilized Syntinate carrier. |
| Stable |
Syntinate products require no special storage conditions or handling and can be used “off-the-shelf.” |
 |
||||||
 |
 |
ORTHOCON® estimates that over 3.5 million patients undergoing surgeries in the United States and Europe each year could benefit from the intraoperative use of HEMASORB.
 |
|
Canaan Partners Closes $600 Million Fund, Canaan IX
January 9, 2012 - Click to Read More ORTHOCON® Announces Signing of Exclusive, Worldwide License Agreement with Bezwada Biomedical August 31, 2011 - Click to Download |
||
|
||||||
